Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Rosemary may help reduce dyspepsia and gastric cancer risk.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

A new drug strategy improves hair loss treatment with better results and safety.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Blocking mTORC1 reduces skin tumor growth in mice.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Lower SMAD2/3 activation predicts more severe skin cancer.

Including androgens in hormone therapy may lower breast cancer risk.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Targeting the Smoothened receptor shows promise for treating certain cancers.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.